201 related articles for article (PubMed ID: 14746421)
1. Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease.
Dang G; Matern R; Bivalacqua TJ; Sikka S; Hellstrom WJ
South Med J; 2004 Jan; 97(1):42-6. PubMed ID: 14746421
[TBL] [Abstract][Full Text] [Related]
2. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
[TBL] [Abstract][Full Text] [Related]
3. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
[TBL] [Abstract][Full Text] [Related]
4. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
[TBL] [Abstract][Full Text] [Related]
5. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
[TBL] [Abstract][Full Text] [Related]
6. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
[TBL] [Abstract][Full Text] [Related]
7. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Intralesional Therapy for Peyronie's Disease in Controlled Clinical Studies: A Systematic Review and Network Meta-Analysis.
Russo GI; Cacciamani G; Cocci A; Kessler TM; Morgia G; Serefoglu EC; Albersen M; Verze P;
J Sex Med; 2019 Feb; 16(2):289-299. PubMed ID: 30692028
[TBL] [Abstract][Full Text] [Related]
9. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
Lacy GL; Adams DM; Hellstrom WJ
Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
[TBL] [Abstract][Full Text] [Related]
10. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
11. Penile duplex ultrasonography in men with Peyronie's disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?
Chung E; De Young L; Brock GB
J Sex Med; 2011 Dec; 8(12):3446-51. PubMed ID: 21981553
[TBL] [Abstract][Full Text] [Related]
12. Intralesional recombinant interferon alpha-2b in Peyronie's disease.
Astorga R; Cantero O; Contreras D; del Río-Martín A; Labarta-Beceiro V; Gutiérrez-Elvírez A; Lima-López MA; López-Saura P
Arch Esp Urol; 2000 Sep; 53(7):665-71. PubMed ID: 11037665
[TBL] [Abstract][Full Text] [Related]
13. Penile Doppler sonographic and clinical characteristics in Peyronie's disease and/or erectile dysfunction: an analysis of 1500 men with male sexual dysfunction.
Chung E; Yan H; De Young L; Brock GB
BJU Int; 2012 Oct; 110(8):1201-5. PubMed ID: 22313546
[TBL] [Abstract][Full Text] [Related]
14. Experience with intraplaque injection of verapamil for Peyronie's disease.
Levine LA; Goldman KE; Greenfield JM
J Urol; 2002 Aug; 168(2):621-5; discussion 625-6. PubMed ID: 12131321
[TBL] [Abstract][Full Text] [Related]
15. The relationship between diabetes mellitus, impotence and veno-occlusive dysfunction in Peyronie's disease patients.
Culha M; Alici B; Acar O; Mutlu N; Gökalp A
Urol Int; 1998; 60(2):101-4. PubMed ID: 9563148
[TBL] [Abstract][Full Text] [Related]
16. Intralesional hyaluronic acid: an innovative treatment for Peyronie's disease.
Gennaro R; Barletta D; Paulis G
Int Urol Nephrol; 2015 Oct; 47(10):1595-602. PubMed ID: 26257044
[TBL] [Abstract][Full Text] [Related]
17. Inflatable penile prosthesis placement in men with Peyronie's disease and drug-resistant erectile dysfunction: A single-center study.
Levine LA; Benson J; Hoover C
J Sex Med; 2010 Nov; 7(11):3775-83. PubMed ID: 20722782
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.
Serefoglu EC; Smith TM; Kaufman GJ; Liu G; Yafi FA; Hellstrom WJG
Urology; 2017 Sep; 107():155-160. PubMed ID: 28554517
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of intralesional interferon-α2B for the treatment of Peyronie disease.
Trost LW; Ates E; Powers M; Sikka S; Hellstrom WJ
J Urol; 2013 Dec; 190(6):2194-9. PubMed ID: 23688848
[TBL] [Abstract][Full Text] [Related]
20. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
